Mersana Therapeutics, Inc. (MRSN) Free Cash Flow by Year
Mersana Therapeutics, Inc. recorded an outflow of $82.5M in free cash flow in fiscal year 2024. This represents an increase of 51.8% from the prior fiscal year. Over the trailing 12 months, Q4 FY2024 through Q3 FY2025, the same line adds up to an outflow of $74.4M in free cash flow. The table below carries 10 fiscal years, from 2015 to 2024, and the quarters Mersana Therapeutics, Inc. has filed alongside them.
Annual figures, oldest first. Point at a bar to read its period.
MRSN Free Cash Flow by Fiscal Year
Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.
TTM is the trailing twelve months, Q4 FY2024 through Q3 FY2025, summed from the four most recent quarterly filings.
MRSN Free Cash Flow by Quarter
Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.
What free cash flow means
Free cash flow is the cash operations produced over the period, less what the company spent on property, plant and equipment, so it answers what was left over rather than what was earned on paper.
More Mersana Therapeutics, Inc. financials
Frequently Asked Questions
What was Mersana Therapeutics, Inc.'s free cash flow in fiscal year 2024?
Mersana Therapeutics, Inc. recorded an outflow of $82.5M in free cash flow in fiscal year 2024.
How fast is Mersana Therapeutics, Inc.'s free cash flow growing?
Mersana Therapeutics, Inc. (MRSN) free cash flow rose by 51.8% year over year, from -$171.1M to -$82.5M in fiscal year 2024.
What is Mersana Therapeutics, Inc.'s free cash flow over the last twelve months?
Mersana Therapeutics, Inc. (MRSN) reported an outflow of $74.4M in free cash flow over the trailing 12 months, Q4 FY2024 through Q3 FY2025, summed from the four most recent quarterly filings.
How has Mersana Therapeutics, Inc.'s free cash flow changed over the years?
Across the 10 fiscal years this page covers, Mersana Therapeutics, Inc. (MRSN) free cash flow went from -$10.3M in fiscal year 2015 to -$82.5M in fiscal year 2024.
What was Mersana Therapeutics, Inc.'s free cash flow in the most recent quarter?
Mersana Therapeutics, Inc. (MRSN) reported -$3.2M in free cash flow in Q3 2025. This represents an increase of 62.8% from the same quarter a year earlier.
What does free cash flow mean on a financial statement?
Free cash flow is the cash operations produced over the period, less what the company spent on property, plant and equipment, so it answers what was left over rather than what was earned on paper. This page lists what Mersana Therapeutics, Inc. (MRSN) reported on that line in every period on record.